Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Hypokalemia | Research

Association between preoperative hypokalemia and postoperative complications in elderly patients: a retrospective study

Authors: Tiantian Chu, Zongfang Wu, Aijun Xu

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Background

Hypokalemia is a common form of electrolyte disorder, which has a higher incidence in hospitalized patients and is closely related to perioperative complications and prognosis. Due to decreased skeletal muscle mass which causes total body potassium reduction, and increased comorbidities, the elderly are more susceptible to hypokalemia.

Objective

To investigate preoperative hypokalemia in elderly patients and its effect on postoperative complications.

Methods

Data were retrospectively collected from the elderly patients who underwent elective surgery from April 2018 to March 2019 and had preoperative blood gas data available. Patients, with age 60 to 100 years, were divided into hypokalemia group (potassium level < 3.5 mmol/L) and normokalemia group (potassium level between 3.5 and 5.5 mmol/L) according to preoperative blood gas analysis. Hypokalemia can be divided into mild (potassium level 3.0 to 3.5 mmol/L), moderate (potassium level 2.5 to 3.0 mmol/L) and severe (potassium level < 2.5 mmol/L), respectively. The risk factors of preoperative hypokalemia and its impact on postoperative complications and prognosis were primary outcomes. Secondary outcomes included postanesthesia care unit (PACU) stay time and hospital length of stay (LOS).

Results

Of 987 participants, 436 (44.17%) developed preoperative hypokalemia, among them 357 (81.88%) mild, 87 (16.74%) moderate and 6 (1.38%) severe. Multivariate logistic regression showed that female gender (OR, 1.851; 95% CI, 1.415–2.421), pre-existing hypokalemia at admission (OR, 4.498; 95% CI, 2.506–8.071), and oral laxative twice or more (OR, 1.823; 95% CI, 1.266–2.624) are risk factors of preoperative hypokalemia. Gynecological and biliopancreatic surgery were more common in hypokalemia group than normokalemia group (P <  0.001, P <  0.05). There was no significant difference in postoperative complications, PACU stay time, LOS, and 30-day mortality between the two groups (all P >  0.05).

Conclusions

Female gender, pre-existing hypokalemia at admission, and oral laxative twice or more are independent risk factors for preoperative hypokalemia in elderly patients. However, postoperative complications and 30-day mortality were not increased, which may be related to monitoring blood gas analysis and prompt correction of potassium levels during surgery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Krogager ML, Kragholm K, Thomassen JQ, Sogaard P, Lewis BS, Wassmann S, et al. Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on cardiovascular pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2021;7(6):557–67. https://doi.org/10.1093/ehjcvp/pvab038.CrossRefPubMed Krogager ML, Kragholm K, Thomassen JQ, Sogaard P, Lewis BS, Wassmann S, et al. Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on cardiovascular pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2021;7(6):557–67. https://​doi.​org/​10.​1093/​ehjcvp/​pvab038.CrossRefPubMed
2.
go back to reference Salim L. Approach to Hypokalemia. Acta Med Indones. 2007;39(1):56–64. Salim L. Approach to Hypokalemia. Acta Med Indones. 2007;39(1):56–64.
3.
go back to reference Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2015;92(6):487–95.PubMed Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2015;92(6):487–95.PubMed
29.
go back to reference Kleinfeld M, Borra S, Gavani S, Corcoran A. Hypokalemia: are elderly females more vulnerable? J Natl Med Assoc. 1993;85(11):861–4.PubMedPubMedCentral Kleinfeld M, Borra S, Gavani S, Corcoran A. Hypokalemia: are elderly females more vulnerable? J Natl Med Assoc. 1993;85(11):861–4.PubMedPubMedCentral
41.
go back to reference Ebrahim M, Larsen PB, Hannani D, Liest S, Jørgensen LN, Jørgensen HL. Preoperative risk factors including serum levels of potassium, sodium, and creatinine for early mortality after open abdominal surgery: a retrospective cohort study. BMC Surg. 2021;21(1). https://doi.org/10.1186/s12893-021-01070-0. Ebrahim M, Larsen PB, Hannani D, Liest S, Jørgensen LN, Jørgensen HL. Preoperative risk factors including serum levels of potassium, sodium, and creatinine for early mortality after open abdominal surgery: a retrospective cohort study. BMC Surg. 2021;21(1). https://​doi.​org/​10.​1186/​s12893-021-01070-0.
Metadata
Title
Association between preoperative hypokalemia and postoperative complications in elderly patients: a retrospective study
Authors
Tiantian Chu
Zongfang Wu
Aijun Xu
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Hypokalemia
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03445-1

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine